IRB Barcelona, along with another 30 Catalan companies and organisations, is participating in the four-day convention in San Diego.
The BIO International Convention (BIO) is the top partnering fair for the biomedical sector.
The Institute’s spin-offs Iproteos and Nostrum Biodiscovery are also visiting the fair.
“It is a great honour and it strengthens my commitment to continuing my research with the highest standards,” says the IRB Barcelona group leader.
Eight IRB Barcelona group leaders are currently members of the European Molecular Biology Organization.
The IRB Barcelona scientists is presented the prize in recognition of his research into cancer and fats.
The foundation, which is based in Madrid, awards Batlle for his research of excellence on colon cancer—one of the tumours with greatest prevalence worldwide.The foundation, which is based in Madrid, awards Batlle for his research of excellence on colon cancer—one of the tumours with greatest prevalence worldwide.
On May 27-28, the Barcelona Science Festival will bring a hundred science activities to the Parc de la Ciutadella.
IRB Barcelona is to participate in the Festival by giving a talk on Network Medicine and holding two workshops for a wide range of public.
During 2017, five activities programmed by the Institute to promote scientific culture will be supported by the FECYT.
Last Saturday IRB Barcelona held its Open Day and received around 400 visitors.
Public of all ages visited the labs, participated in workshops and attended talks at the centre, which is located at the Barcelona Science Park.
The renowned scientist joins the Institute for Research in Biomedicine (IRB Barcelona) after 13 years at CNIO, funded by the “la Caixa” Banking Foundation and by the Government of Catalonia's ICREA programme.
Manuel Serrano will study how damaged tissue is repaired and search for therapies based on regenerative medicine for the treatment of diabetes and other diseases.
From cancer to tissue repair, from CNIO to IRB Barcelona
The project, headed by group leader and ICREA researcher Eduard Batlle, receives a 60,000-€ grant.
The study will test the effectiveness of immunotherapies to treat metastatic disease in advanced colorectal cancer.
Research will take place during the academic years 2017 and 2018.